Page 338 - ATP-P 11th Ed

Side-effects:
• Anxiety
• Dizziness
• Sedation/drowsiness
• Headache
• Malaise/fatigue
• Chills/shivering
• Constipation or diarrhea
• Fever
• Pruritis
• Urinary retention
• Musculoskeletal pain
• Extrapyramidal symptoms
• Arrhythmias
• Hypotension
SECTION 3 Adverse reactions:
• Chest pain
• Elevated liver transaminases
• Rare cases of hypersensitivity, sometimes severe (anaphylaxis) have been reported.
• Syncope (rare)
• Grand mal seizures (rare)
• Bronchospasm (rare)
• Transient blurred vision (rare)
• Hypokalemia (rare)
• Rifampin may decrease ondansetron levels.
TMEP use:
• K9 Anaphylactic Reactions and Envenomation Protocol
• Nausea and Vomiting Protocol

®
Oral Transmucosal Fentanyl Citrate (OTFC) (Actiq ) Lozenge
GROUNDING medication for personnel on flight status
Description: Opioid – Oral transmucosal fentanyl citrate
Indications: Severe battlefield-related trauma pain
Dose: 400–800mcg
• The blister package should be opened with scissors immediately prior to product use.
The patient should place the Actiq lozenge unit in his or her mouth between the cheek
®
and lower gum, occasionally moving the drug matrix from one side to the other using
the handle. The Actiq unit should be sucked, not chewed. A unit dose of Actiq , if
®
®
chewed and swallowed, might result in lower peak concentrations and lower bioavail-
ability than when consumed as directed.
328 SECTION 3 RECOMMENDED DRUG LIST (RDL)